Home › Compare › CVS vs NKE

CVS vs NKE: Dividend Comparison 2026

CVS yields 4.00% · NKE yields 4.00%● Live data

vsPost on X →
10 years
CVS
CVS
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full CVS calculator →
NKE
NKE
● Live price
4.00%
Share price
$50.00
Annual div
$2.00
5Y div CAGR
5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.0K
Annual income
$899.19
Full NKE calculator →

Portfolio growth — CVS vs NKE

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCVSNKE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CVS + NKE cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CVS pays
NKE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVS
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
NKE
Annual income on $10K today (after 15% tax)
$340.00/yr
After 10yr DRIP, annual income (after tax)
$764.31/yr
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVS + NKE for your $10,000?

CVS: 50%NKE: 50%
100% NKE50/50100% CVS
Portfolio after 10yr
$28.0K
Annual income
$899.20/yr
Blended yield
3.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on NKE right now

CVS
Analyst Ratings
2
Strong
33
Buy
6
Hold
Consensus: Buy
Price Target
$95.15
+90.3% upside vs current
Range: $90.00 — $103.00
Altman Z
2.2
Piotroski
6/9
NKE
Analyst Ratings
1
Strong
42
Buy
23
Hold
4
Sell
Consensus: Buy
Price Target
$75.35
+50.7% upside vs current
Range: $62.00 — $110.00
Altman Z
3.8
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVS buys
0
NKE buys
0
No recent congressional trades found for CVS or NKE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCVSNKE
Forward yield4.00%4.00%
Annual dividend / share$2.00$2.00
Payout ratio50%50%
1-year div growth5%5%
5-year div CAGR5%5%
Portfolio after 10y$28.0K$28.0K
Annual income after 10y$899.19$899.19
Total dividends collected$6.4K$6.4K
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Discretionary
Analyst consensusBuyBuy
Analyst price target$95.15 ✓$75.35

Year-by-year: CVS vs NKE ($10,000, DRIP)

YearCVS PortfolioCVS Income/yrNKE PortfolioNKE Income/yrGap
1$11,120$420.00$11,120$420.00$0.00 → NKE
2$12,357$458.31$12,357$458.31$0.00 → NKE
3$13,721$499.76$13,721$499.76$0.00 → NKE
4$15,227$544.58$15,227$544.58$0.00 → NKE
5$16,885$593.02$16,885$593.02$0.00 → NKE
6$18,713$645.34$18,713$645.34$0.00 → NKE
7$20,724$701.81$20,724$701.81$0.00 → NKE
8$22,938$762.73$22,938$762.73$0.00 → NKE
9$25,372$828.41$25,372$828.41$0.00 → NKE
10$28,047$899.19$28,047$899.19$0.00 → NKE

CVS vs NKE: Complete Analysis 2026

CVS — Healthcare

CVS is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in CVS shares.

Full CVS Calculator →

NKE — Consumer Discretionary

NKE is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NKE shares.

Full NKE Calculator →
📬

Get this CVS vs NKE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVS vs SCHDCVS vs JEPICVS vs OCVS vs KOCVS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.